Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges

Second-generation androgen receptor axis-targeted (ARAT) agents, namely abiraterone and enzalutamide, enable stronger blockade of the androgen receptor (AR) axis and longer survival of men with castration-resistant prostate cancer (CRPC). However, the extent of the improved survival remains insuffic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Kita, Yuki, Goto, Takayuki, Akamatsu, Shusuke, Yamasaki, Toshinari, Inoue, Takahiro, Ogawa, Osamu, Kobayashi, Takashi
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2018
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6210307/
https://ncbi.nlm.nih.gov/pubmed/30248934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10100345
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky